The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
Clinical trial NCT03461042 · COMPLETED
Trial details
- NCT number
- NCT03461042
- Sponsor
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2019-07-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.